Information Provided By:
Fly News Breaks for May 10, 2019
May 10, 2019 | 07:08 EDT
Citi analyst Yigal Nochomovitz downgraded Puma Biotechnology to Neutral from Buy and lowered his price target for the shares to $24 following the company's Q1 results.
News For PBYI From the Last 2 Days
There are no results for your query PBYI